Con esta herramienta te facilitamos un acceso a todas las ofertas y demandas de tecnología europeas y a búsquedas de socios para participar en propuestas europeas de I+D publicadas en la red Enterprise Europe Network, pudiendo filtrar los resultados para facilitar las búsquedas más acordes con tus necesidades.

¿Quieres recibir estos listados de oportunidades de colaboración en tu correo de forma periódica y personalizada? Date de alta en nuestro Boletín

Para optimizar los resultados de la búsqueda, se recomienda utilizar términos en inglés.

H2020 - FTI: Suministro de medicamentos contra el cáncer en forma de aerosoles presurizados

Resumen

Tipo:
Búsqueda de socios
Referencia:
RDDE20160129001
Publicado:
09/02/2016
Caducidad:
03/02/2017
Resumen:
Una pyme alemana va a presentar una propuesta a la convocatoria "Vía rápida hacia la innovación" del programa H2020. El objetivo del proyecto es mejorar el tratamiento de la metástasis peritoneal utilizando una nueva forma de administración de medicamentos en forma de aerosoles presurizados terapéuticos. La tecnología ha sido demostrada en ensayos clínicos. La empresa busca un socio industrial para optimizar la administración tópica de medicamentos aprobados contra el cáncer de ovario en el peritoneo y desarrollar formulaciones avanzadas. La fecha límite de la convocatoria es el 15 de marzo de 2016 y el plazo para presentar expresiones de interés finaliza el 12 de febrero.

Details

Tittle:
Urgent: H2020 - FTI - Delivery of cancer drugs in form of pressurized aerosols - industrial partner sought for optimization of topical delivery and development of advanced formulations
Summary:
A German SME is going to submit a proposal under the call H2020 - Fast Track to Innovation.
The project aims at improving the therapy of peritoneal metastasis by using a new way of delivering drugs in form of pressurized therapeutic aerosols. The technology has been demonstrated in clinical trials. The SME looks for an industrial partner able to optimize topical delivery of approved drugs for ovarian cancer onto/into the peritoneum and to develop advanced formulations.
Description:
A German SME active in the manufacturing of medical devices is preparing a Fast Track to Innovation proposal. The Fast Track to Innovation Pilot in Horizon 2020 promotes any innovation activities close-to the market and is open to all types of participants (especially from industry).
The project aims at implementing an improved therapy of peritoneal metastasis by using a new way of delivering drugs in the form of pressurized therapeutic aerosols.
The proposer´s proprietary technology for the drug delivery is already CE certified and its safety and efficacy have been demonstrated in clinical trials (Phase-2). It is already in use/ introduced in 50 leading hospitals worldwide. Finally the project aims at obtaining marketing authorization (EMA approval) to commercialize the devices for application of therapeutic aerosols with the drugs healing ovarian cancer.

The SME is looking for an industrial partner able to optimize topical delivery of approved drugs onto/into the peritoneum by determining best physico-chemical conditions and developing advanced formulations.
i) Formulation development including: liposomes, nano-suspensions, nanocapsules, nano-emulsions, and drugs not stable in an aqueous formulation
ii) Characterization with respect to droplet size, charge, shape, simulations, granulometric analysis, etc.pH, osmolarity (isotonicity), viscosity, surface tension, refractive index and zeta potential, differential calorimetry.etc.
iii) Stability testing of formulations at various conditions according to EMA (European Medicines Agency), FDA (Food and Drug Administration) and ICH (International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use) Guidelines
iv) Characterization of formulations in ex vivo and in vitro models for the assessment of their tolerability and pharmacokinetics
v) Scale-up of batches including manufacture of clinical trial and production batches

Deadline for expressions of interest is Feb 12, 2016
Deadline of the call is March 15, 2016
Stage of Development:
Proposal under development

Partner sought

Partner Sought:
- Type of partner sought : Industry, SME - Specific area of activity of the partner: Drug formulation, aerosol - Tasks to be performed by the partner: Research and development, manufacturing
Type of Partnership Considered:
RDR

Client

Type and Size of Client:
Industry SME 11-49
Already Engaged in Trans-National Cooperation:
No
Languages Spoken:
English
French
German

Dissemination

Programme-call

Evaluation Scheme:
70% EU funding for industrial partners
Anticipated Project Budget:
up to 3 mio Euro
Coordinator Required:
No
Deadline for Call:
15/03/2016
Project Duration:
104